Alan A. Ades serves as Executive at Organogenesis Holdings Inc., where they oversee executive responsibilities. Since joining the company, Alan A. Ades has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 10, 2018 involved receiving (via award) 781,904 shares valued at $0.
Alan A. Ades currently holds 67,663,882 shares of Organogenesis Holdings Inc. (ORGO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alan A. Ades has been a net neutral trader of ORGO stock. They have purchased $0 and sold $0 worth of shares.
Alan A. Ades's most recent insider trade was on Dec 10, 2018, when they sold 781,904 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 10, 2018 | ORGO | $0 | Award | 6,279,441 | $N/A | Discretionary |